ALBENDAZOLE - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for albendazole and what is the scope of freedom to operate?
Albendazole
is the generic ingredient in two branded drugs marketed by Actavis Elizabeth, Alembic, Chartwell Rx, Cipla Ltd, Dr Reddys, Edenbridge Pharms, MSN, Strides Pharma, Zydus Pharms, and Impax Labs Inc, and is included in ten NDAs. Additional information is available in the individual branded drug profile pages.There are ten drug master file entries for albendazole. Eighteen suppliers are listed for this compound.
Summary for ALBENDAZOLE
US Patents: | 0 |
Tradenames: | 2 |
Applicants: | 10 |
NDAs: | 10 |
Drug Master File Entries: | 10 |
Finished Product Suppliers / Packagers: | 18 |
Raw Ingredient (Bulk) Api Vendors: | 157 |
Clinical Trials: | 119 |
Patent Applications: | 6,305 |
Drug Prices: | Drug price trends for ALBENDAZOLE |
What excipients (inactive ingredients) are in ALBENDAZOLE? | ALBENDAZOLE excipients list |
DailyMed Link: | ALBENDAZOLE at DailyMed |
Recent Clinical Trials for ALBENDAZOLE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Kintampo Health Research Centre, Ghana | N/A |
Public Health Laboratory Ivo de Carneri | Phase 3 |
National Public Health Institute of Liberia | Phase 2 |
Pharmacology for ALBENDAZOLE
Drug Class | Anthelmintic |
Mechanism of Action | Cytochrome P450 1A Inducers |
Medical Subject Heading (MeSH) Categories for ALBENDAZOLE
Anatomical Therapeutic Chemical (ATC) Classes for ALBENDAZOLE
US Patents and Regulatory Information for ALBENDAZOLE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Zydus Pharms | ALBENDAZOLE | albendazole | TABLET;ORAL | 208979-001 | Dec 14, 2018 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Strides Pharma | ALBENDAZOLE | albendazole | TABLET;ORAL | 210011-001 | Dec 7, 2018 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Alembic | ALBENDAZOLE | albendazole | TABLET;ORAL | 215652-001 | Sep 4, 2024 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Edenbridge Pharms | ALBENDAZOLE | albendazole | TABLET;ORAL | 211117-001 | May 14, 2019 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Msn | ALBENDAZOLE | albendazole | TABLET;ORAL | 213435-001 | Jan 21, 2021 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Chartwell Rx | ALBENDAZOLE | albendazole | TABLET;ORAL | 211636-001 | Jun 10, 2020 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.